Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 8 June 2026 - 16:08

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/omjjara

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters